Signia Therapeutics announces it has been invited to present company and update of development at the upcoming 6th ISIRV-AVG “Advances in Respiratory Virus Therapeutics”. Presentation will be delivered by Dr. Andrés Pizzorno, cofounder of Signia Therapeutics and Project Manager, as invited speaker, on Tuesday November 13th at 9.30 am. Dr. Pizzorno will be presenting an overview of Signia … Continue reading Signia Therapeutics to present preclinical results at the 6th ISIRV-AVG Antiviral Conference